In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Chupps commissions disappearing billboard to spotlight its biodegradable sandals
In India, footwear brand Chupps has created a sandal-shaped billboard that is made to disappear over time.
The unique advertisement, which is located in...
CJ Biomaterials to supply PHAs for biobased turf
In South Korea, CJ Biomaterials has partnered with Sweden’s BIQ Materials to produce artificial turf infill made with CJ’s PHACT™ polyhydroxyalkanoate.
Infill, commonly used...
New York “Living Room” exhibit spotlights sustainable materials in domestic design
In New York, an exhibit at Fugue Gallery is spotlighting the potential of renewable and reclaimed materials in design.
Curated by Helena Elston, Living...